Clinico-Laboratory Features of Multiple Myeloma in Selected Patients at University of Ilorin Teaching Hospital, North Central Nigeria

Simple item page
dc.contributor.authorBabatunde, A.S
dc.contributor.authorOmokanye, K.O
dc.contributor.authorOgunfemi, M.K
dc.contributor.authorOwoeye, O.A
dc.contributor.authorSanni, E.O
dc.contributor.authorDurotoye, I A.
dc.contributor.authorShittu, A.O.
dc.date.accessioned2023-06-13T09:26:17Z
dc.date.available2023-06-13T09:26:17Z
dc.date.issued2020-03
dc.description.abstractMultiple myeloma is an haematological disorder characterized by clonal proliferation of bone marrow plasma cells with production of increased amounts of monoclonal immunoglobulins which are detectable in blood and/or urine. The aim of the study was to describe the clinical and laboratory characteristics as well as treatment outcome in multiple myeloma patients diagnosed and managed at the Haematology Department of the University of Ilorin Teaching Hospital (U.I.T.H), Ilorin, North Central Nigeria, between 1 st January 2008 and 31 st December 2018. The study materials included bone marrow registers from the department and case folders of all multiple myeloma patients diagnosed within the study period. Relevant data including socio-demographic characteristics of patients, clinical features at presentation and laboratory tests results were extracted, documented and analyzed. Diagnosis was made in all patients based on the presence of major and/or minor criteria as described by the International Myeloma Working Group guidelines. Fifty eight (58) patients were diagnosed with multiple myeloma comprising of 31 males and 27 females (M:F ratio = 1.15:1). The median age of patients was 62.6 years (range = 39 – 85 years), and the most common presenting features included back pains (86.2%), bone pains (69%), inability to walk (67.2%) and anaemia (67.2%). High erythrocyte sedimentation rate > 30mm/Hr was seen in all patients (100%), Immunoglobulin G (Ig G) was the commonest monoclonal immunoglobulin demonstrated on serum protein electrophoresis (82.8%), and “punched out” osteolytic bone lesion on X-rays was demonstrated in 79.3% of cases. In resource- limited settings such as ours, the diagnosis and monitoring of patients with multiple myeloma still rely on the clinical and laboratory features of the disease to a large extent, hence the need for haemato-oncologists and physicians to be conversant with these features.en_US
dc.identifier.citationBabatunde, A.S., Durotoye, I.A., Shittu, A.O., Omokanye, K.O., Ogunfemi, M.K., Owoeye, O.A., Sanni, E.O.en_US
dc.identifier.urihttps://uilspace.unilorin.edu.ng/handle/20.500.12484/11083
dc.language.isoenen_US
dc.publisherLibrary and Publications Committee, University of Ilorin, Nigeriaen_US
dc.subjectMultiple myeloma, clinico-laboratory, features, UITHen_US
dc.titleClinico-Laboratory Features of Multiple Myeloma in Selected Patients at University of Ilorin Teaching Hospital, North Central Nigeriaen_US
dc.typeArticleen_US

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Babatunde AS 2020 Clinicopathologic features and outcome of CLL in Ilorin.pdf
Size:
3.7 MB
Format:
Adobe Portable Document Format
Description:
Main article
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections